Viewing data from:

METHSCOPOLAMINE BROMIDE

ANDA

METHSCOPOLAMINE BROMIDE | A216786 | NE RX PHARMA LLC

2 strengths0 unique patents0 unique exclusivities

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

PHYTEX AUSTRALIA PVT LTDMETHSCOPOLAMINE BROMIDE

DMF 74101988

ALKALOIDS PRIVATE LTDMETHSCOPOLAMINE BROMIDE

DMF 286292014

ALCHEM INTERNATIONAL PRIVATE LTDMETHSCOPOLAMINE BROMIDE USP

DMF 298052015

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveMETHSCOPOLAMINE BROMIDE

DMF 180692005

VITAL LABORATORIES PVT LTDInactiveMETHSCOPOLAMINE BROMIDE

DMF 309622016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 1, 2024

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 1, 2024